What is Scotiabank's Forecast for Albemarle FY2026 Earnings?

Key Points

• Scotiabank cut its FY2026 EPS forecast for Albemarle to $10.36 from $11.64 and projects FY2027 EPS of $9.98. Its rating remains “Sector Outperform,” with a $165 price target.
• Albemarle’s latest quarterly results topped estimates: EPS was $2.58 versus $2.53 expected, while revenue of $1.55 billion beat the $1.52 billion consensus and grew 18.8% year over year.
• Analyst sentiment is broadly positive: MarketBeat reports a “Moderate Buy” consensus rating and an average price target of $174.05.

Albemarle Corporation (NYSE:ALB - Free Report) - Analysts at Scotiabank cut their FY2026 EPS estimates for Albemarle in a research report issued on Monday, November 9th. Scotiabank analyst B. Isaacson now anticipates that the specialty chemicals company will post earnings of $10.36 per share for the year, down from their prior estimate of $11.64. Scotiabank has a "Sector Outperform" rating and a $165.00 price objective on the stock. The consensus estimate for Albemarle's current full-year earnings is $10.84 per share. Scotiabank also issued estimates for Albemarle's FY2027 earnings at $9.98 EPS.

Albemarle (NYSE:ALB - Get Free Report) last issued its quarterly earnings data on Wednesday, November 4th. The specialty chemicals company reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.53 by $0.05. Albemarle had a net margin of 10.40% and a return on equity of 14.91%. The company had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.52 billion. During the same quarter in the prior year, the firm earned ($0.19) earnings per share. The firm's revenue was up 18.8% compared to the same quarter last year.

A number of other research analysts also recently issued reports on the company. Citigroup increased their price objective on Albemarle from $125.00 to $140.00 and gave the stock a "buy" rating in a report on Monday. Zacks Research raised Albemarle from a "strong sell" rating to a "hold" rating in a research report on Monday. Truist Financial reaffirmed a "buy" rating and set a $170.00 price target (down from $185.00) on shares of Albemarle in a research report on Friday, November 6th. Mizuho raised shares of Albemarle from a "neutral" rating to an "outperform" rating and set a $130.00 price target for the company in a research note on Wednesday, October 14th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Albemarle from $160.00 to $140.00 and set a "neutral" rating on the stock in a report on Tuesday, August 25th. Fifteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $174.05.

Albemarle Stock Performance

Shares of Albemarle stock opened at $94.98 on Wednesday. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.34 and a quick ratio of 1.57. The firm has a market cap of $11.21 billion, a price-to-earnings ratio of 22.94, a price-to-earnings-growth ratio of 0.61 and a beta of 1.34. The stock's 50-day moving average is $106.02 and its 200-day moving average is $147.00. Albemarle has a one year low of $89.77 and a one year high of $221.00.

Albemarle Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, December 18th will be given a dividend of $0.41 per share. The ex-dividend date of this dividend is Friday, December 18th. This represents a $1.64 annualized dividend and a dividend yield of 1.7%. Albemarle's payout ratio is 39.61%.

Institutional Investors Weigh In On Albemarle

Institutional investors and hedge funds have recently made changes to their positions in the stock. Addison Advisors LLC bought a new position in shares of Albemarle in the second quarter valued at $28,000. Dakota Community Bank & Trust NA bought a new stake in Albemarle during the first quarter worth $54,000. Fiduciary Financial Advisors bought a new stake in Albemarle during the second quarter worth $41,000. Valley National Advisers Inc. lifted its stake in Albemarle by 3,700.0% in the third quarter. Valley National Advisers Inc. now owns 304 shares of the specialty chemicals company's stock valued at $32,000 after acquiring an additional 296 shares during the last quarter. Finally, Jones Financial Companies Lllp acquired a new stake in Albemarle in the second quarter valued at $42,000. Institutional investors own 92.87% of the company's stock.

About Albemarle

Albemarle Corporation is a specialty chemicals company that produces lithium, bromine and refining catalysts. Its products serve industries including energy storage, transportation, electronics, petroleum refining and pharmaceuticals. The company supplies lithium compounds used in rechargeable batteries and other applications. It also makes bromine-based products for uses such as flame retardants and water treatment, along with catalysts used in refining petroleum. Albemarle traces its history to 1887 and is headquartered in Charlotte, North Carolina.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.